J. Rousseau

发表

Mutations that prevent associative learning in C. elegans.

D. van der Kooy, D. Kooy, J. Y. Wen, 1997, Behavioral neuroscience.

Meganucleases can restore the reading frame of a mutated dystrophin

J. Rousseau, J. Tremblay, F. Pâques, 2010, Gene Therapy.

Dystrophin Expression following the Transplantation of Normal Muscle Precursor Cells Protects mdx Muscle from Contraction-Induced Damage

Nicolas A. Dumont, J. Rousseau, J. Tremblay, 2010, Cell transplantation.

Real-time imaging of myoblast transplantation using the human sodium iodide symporter.

J. Rousseau, J. Tremblay, L. Jobin, 2005, BioTechniques.

Central Tolerance to Myogenic Cell Transplants Does Not Include Muscle Neoantigens

J. Rousseau, J. Tremblay, M. Sykes, 2008, Transplantation.

Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy.

Nicolas A. Dumont, J. Rousseau, J. Frenette, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Characterization of frataxin gene network in Friedreich's ataxia fibroblasts using the RNA-Seq technique.

F. Raymond, J. Corbeil, J. Rousseau, 2016, Mitochondrion.

Induction of Anoikis Following Myoblast Transplantation into SCID Mouse Muscles Requires the Bit1 and FADD Pathways

J. Rousseau, B. Benabdallah, M. Bouchentouf, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts.

Eric C. Olivares, E. Olivares, J. Rousseau, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Overexpression of Follistatin in Human Myoblasts Increases Their Proliferation and Differentiation, and Improves the Graft Success in SCID Mice

J. Rousseau, B. Benabdallah, M. Bouchentouf, 2009, Cell transplantation.

Inhibiting Myostatin with Follistatin Improves the Success of Myoblast Transplantation in Dystrophic Mice

D. Scherman, J. Rousseau, P. Bigey, 2008, Cell transplantation.

Prime Editing Permits the Introduction of Specific Mutations in the Gene Responsible for Duchenne Muscular Dystrophy

G. Tremblay, J. Rousseau, Pouiré Yaméogo, 2022, International journal of molecular sciences.

Prime editing optimized RTT permits the correction of the c.8713C>T mutation in DMD gene

J. Rousseau, A. Bigot, K. Mamchaoui, 2022, Molecular therapy. Nucleic acids.

Myoblasts Derived From Normal hESCs and Dystrophic hiPSCs Efficiently Fuse With Existing Muscle Fibers Following Transplantation

J. Rousseau, J. Gekas, N. Huot, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

CRISPR-induced deletion with SaCas9 restores dystrophin expression in dystrophic models in vitro and in vivo

J. Rousseau, D. Ouellet, Dominique L. Ouellet, 2018, bioRxiv.

RCAS1 is associated with ductal breast cancer progression.

J. Rousseau, C. Doillon, M. Audette, 2002, Biochemical and biophysical research communications.

Increased Expression of Laminin Subunit Alpha 1 Chain by dCas9-VP160

J. Rousseau, A. Perrin, J. Tremblay, 2016, Molecular therapy. Nucleic acids.

Novel Duchenne Muscular Dystrophy Treatment Through Myoblast Transplantation Tolerance with Anti‐CD45RB, Anti‐CD154 and Mixed Chimerism

J. Rousseau, J. Tremblay, D. Rothstein, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

From gRNA Identification to the Restoration of Dystrophin Expression: A Dystrophin Gene Correction Strategy for Duchenne Muscular Dystrophy Mutations Using the CRISPR-Induced Deletion Method.

J. Rousseau, D. Ouellet, Dominique L. Ouellet, 2018, Methods in molecular biology.

Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia

J. Rousseau, D. Ouellet, J. Tremblay, 2016, Gene Therapy.

Modulation of prolactin expression by xenoestrogens.

J. Rousseau, L. Cossette, M. Martinoli, 2002, General and comparative endocrinology.

Corrigendum to “Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method”

J. Rousseau, P. Lagüe, P. Chapdelaine, 2016, Molecular therapy. Nucleic acids.

Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method

J. Rousseau, P. Lagüe, P. Chapdelaine, 2016, Molecular therapy. Nucleic acids.

Development of an AAV9 coding for a 3XFLAG-TALEfrat#8-VP64 able to increase in vivo the human frataxin in YG8R mice

J. Rousseau, P. Chapdelaine, D. Ouellet, 2016, Gene Therapy.